Newer data suggest a significant reduction in cardiovascular events with GLP-1 agonist therapy in patients who are overweight or obese and have a prior history of heart disease
John Tomase John Tomase Published Mar 9, 2026 Months of rancor between Novo Nordisk and Hims & Hers came to an end Monday when the companies agreed to sell obesity drugs together
Thus, tirzepatide has demonstrated significant efficacy in lowering HbA1c levels and body weight in individuals with T2D, often surpassing the results seen with other antidiabetic agents
Our entire practice is built on a foundation of medical science and patient safety, and that means we have a responsibility to cut through the noise
La idea que subyace a esto es el gran cuerpo de investigacin cientfica que tiene el ALCAR en su uso como complemento alimenticio , y cmo el comportamiento de la carnitina y el grupo acetilo, condiciona su inters, algo que ha impulsado su presencia en distintas rutinas, junto con hbitos, descanso, organizacin de horarios y una alimentacin que acompae